LAURUS LABS
Back to Cashflow Statement
|
LAURUS LABS Last 5 Year Net Cash Inflow / Outflow History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Net Cash Inflow / Outflow | ₹-41 Cr | ₹93 Cr | ₹-29 Cr | ₹27 Cr | ₹47 Cr |
What is the latest Net Cash Inflow / Outflow ratio of LAURUS LABS ?
| Year | Net Cash Inflow / Outflow |
|---|---|
| Mar2025 | ₹-41 Cr |
| Mar2024 | ₹93 Cr |
| Mar2023 | ₹-29 Cr |
| Mar2022 | ₹27 Cr |
| Mar2021 | ₹47 Cr |
How is Net Cash Inflow / Outflow of LAURUS LABS Trending?
| Years | Net Cash Inflow / Outflow | % Change | |
|---|---|---|---|
| Mar2025 | ₹-41 Cr | Negative | |
| Mar2024 | ₹93 Cr | Positive | |
| Mar2023 | ₹-29 Cr | Negative | |
| Mar2022 | ₹27 Cr | -42.15 | |
| Mar2021 | ₹47 Cr | - | |
Compare Net Cash Inflow / Outflow of peers of LAURUS LABS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| LAURUS LABS | ₹54,486.7 Cr | -0.9% | 0.3% | 74.7% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹430,705.0 Cr | -0.7% | 2% | -1.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹167,091.0 Cr | -2.1% | -2.8% | 7.8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹127,555.0 Cr | -0.9% | -0.6% | 12.2% | Stock Analytics | |
| CIPLA | ₹120,919.0 Cr | -1% | -1.2% | 3.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹106,165.0 Cr | -0.1% | 2.3% | 2.6% | Stock Analytics | |
LAURUS LABS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| LAURUS LABS | -0.9% |
0.3% |
74.7% |
| SENSEX | 0.2% |
-0.5% |
4% |
You may also like the below Video Courses